TSHR and cancer: This study demonstrated that the radiolabeled superagonist rhTSH analogue (TR1402) has high affinity for the TSHR and, in dogs with spontaneous thyroid cancer, shows a high T/B ratio able to image an intrathyroidal cancer lesion.